NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

See in the figure the replacement of BCG that Merck has the monopoly? What is the connection between the company that has the BCG replacement and Yorkville?

Don't look down on Yorkville. Its investment is long-term. It strikes me Yorkville is building an ecosystem with DCVAX as the center too. Just like what Merck, Amgen, Baker Brothers and others have been doing over the past five or ten years.

I don't worry about the approval at all. My only concern is how I can load more.

$NWBOhttps://t.co/6muteDK2u0
BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it has entered into… https://t.co/z9okR3yN7i

— d_stock (@d_stock07734) November 21, 2025

$NWBO

Better terms. And Yorkville can keep accumulating more shares.

Total Raised: $5,000,000
Net Proceeds: $4,750,000
Total Costs: $250,000
Costs as % of Total Raised: 5%

11-3-2025
CytoDyn Secures $30 Million Commitment from Yorkville Advisors https://t.co/jllHPCHjc3… https://t.co/2U2GorgchL

— d_stock (@d_stock07734) November 20, 2025